Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Author: Benzinga Insights | May 10, 2023 09:06am

Gainers

  • CTI BioPharma (NASDAQ:CTIC) stock rose 85.1% to $8.92 during Wednesday's pre-market session. The company's market cap stands at $1.1 billion.
  • Addex Therapeutics (NASDAQ:ADXN) shares moved upwards by 37.95% to $1.03. The market value of their outstanding shares is at $15.2 million.
  • Sharps Technology (NASDAQ:STSS) stock increased by 30.47% to $1.27. The company's market cap stands at $14.8 million.
  • TScan Therapeutics (NASDAQ:TCRX) shares rose 26.17% to $4.29. The market value of their outstanding shares is at $105.6 million. As per the news, the Q1 earnings report came out today.
  • Tivic Health Systems (NASDAQ:TIVC) shares increased by 14.93% to $0.18. The company's market cap stands at $5.2 million.
  • Indaptus Therapeutics (NASDAQ:INDP) stock increased by 14.85% to $2.32. The market value of their outstanding shares is at $19.4 million.

Losers

  • Babylon Holdings (NYSE:BBLN) stock fell 54.8% to $3.2 during Wednesday's pre-market session. The company's market cap stands at $79.5 million. As per the press release, Q1 earnings came out today.
  • SeaStar Medical Holding (NASDAQ:ICU) shares decreased by 31.96% to $1.32. The market value of their outstanding shares is at $17.5 million.
  • Cutera (NASDAQ:CUTR) shares fell 15.85% to $17.0. The company's market cap stands at $336.4 million. The company's, Q1 earnings came out yesterday.
  • Biote (NASDAQ:BTMD) stock fell 14.07% to $5.5. The company's market cap stands at $101.8 million. As per the press release, Q1 earnings came out yesterday.
  • Oncorus (NASDAQ:ONCR) shares decreased by 12.7% to $0.3. The market value of their outstanding shares is at $7.7 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares decreased by 12.41% to $3.6. The company's market cap stands at $4.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADXN BBLN BTMD CTIC CUTR ENSC ICU INDP ONCR STSS TCRX TIVC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist